Tissue Eng Regen Med.
2019 Oct;16(5):479-490. 10.1007/s13770-019-00206-x.
In Situ Gelling Hydrogel with Anti-Bacterial Activity and Bone Healing Property for Treatment of Osteomyelitis
- Affiliations
-
- 1Department of Advanced Materials and Chemical Engineering, Hannam University, Daejeon 34054, Republic of Korea. jhlee@hnu.kr
- 2Department of Nanobiomedical Science, Dankook University, Cheonan 31116, Republic of Korea.
- 3Department of Pharmaceutical Engineering, Dankook University, Cheonan 31116, Republic of Korea.
- 4Department of Biological Science and Biotechnology, Hannam University, Daejeon 34054, Republic of Korea.
- 5Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju 52727, Republic of Korea.
- KMID: 2464068
- DOI: http://doi.org/10.1007/s13770-019-00206-x
Abstract
- BACKGROUND
Despite the development of progressive surgical techniques and antibiotics, osteomyelitis is a big challenge for orthopedic surgeons. The main aim of this study is to fabricate an in situ gelling hydrogel that permits sustained release of antibiotic (for control of infection) and growth factor (for induction of new bone formation) for effective treatment of osteomyelitis.
METHODS
An in situ gelling alginate (ALG)/hyaluronic acid (HA) hydrogel containing vancomycin (antibiotic) and bone morphogenetic protein-2 (BMP-2; growth factor) was prepared by simple mixing of ALG/HA/Naâ‚‚HPOâ‚„ solution and CaSOâ‚„/vancomycin/BMP-2 solution. The release behaviors of vancomycin and BMP-2, anti-bacterial effect (in vitro); and therapeutic efficiency for osteomyelitis and bone regeneration (in vivo, osteomyelitis rat model) of the vancomycin and BMP-2-incorporated ALG/HA hydrogel were investigated.
RESULTS
The gelation time of the ALG/HA hydrogel was controlled into approximately 4 min, which is sufficient time for handling and injection into osteomyelitis lesion. Both vancomycin and BMP-2 were continuously released from the hydrogel for 6 weeks. From the in vitro studies, the ALG/HA hydrogel showed an effective anti-bacterial activity without significant cytotoxicity for 6 weeks. From an in vivo animal study using Sprague-Dawley rats with osteomyelitis in femur as a model animal, it was demonstrated that the ALG/HA hydrogel was effective for suppressing bacteria (Staphylococcus aureus) proliferation at the osteomyelitis lesion and enhancing bone regeneration without additional bone grafts.
CONCLUSIONS
From the results, we suggest that the in situ gelling ALG/HA hydrogel containing vancomycin and BMP-2 can be a feasible therapeutic tool to treat osteomyelitis.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Cyst-like Destructive Lesions of Calcaneus
- Acute Osteomyelitis of Superior Maxilla, Zygomatic and Frontal bone of Orbital Margin
- The Use of Vancomycin-impregnated Polymethylmetactylate Beads for the Treatment of Chronic Osteomyelitis
- Negative-Pressure Wound Therapy in a Patient with Osteomyelitis Caused by Multidrug-Resistant Bacterial Infection: A Case Report
- Primary subacute Osteomyelitis in Children: A Retrospective Review
